JP2023534951A5 - - Google Patents
Info
- Publication number
- JP2023534951A5 JP2023534951A5 JP2023502828A JP2023502828A JP2023534951A5 JP 2023534951 A5 JP2023534951 A5 JP 2023534951A5 JP 2023502828 A JP2023502828 A JP 2023502828A JP 2023502828 A JP2023502828 A JP 2023502828A JP 2023534951 A5 JP2023534951 A5 JP 2023534951A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063052811P | 2020-07-16 | 2020-07-16 | |
| US63/052,811 | 2020-07-16 | ||
| PCT/US2021/041946 WO2022016043A1 (en) | 2020-07-16 | 2021-07-16 | Conjugated oligonucleotides for tissue specific delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023534951A JP2023534951A (ja) | 2023-08-15 |
| JPWO2022016043A5 JPWO2022016043A5 (https=) | 2024-07-25 |
| JP2023534951A5 true JP2023534951A5 (https=) | 2024-07-25 |
Family
ID=79554340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502828A Pending JP2023534951A (ja) | 2020-07-16 | 2021-07-16 | 組織特異的送達のためのコンジュゲートされたオリゴヌクレオチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220042015A1 (https=) |
| EP (1) | EP4181932A4 (https=) |
| JP (1) | JP2023534951A (https=) |
| CN (1) | CN116600817A (https=) |
| AU (1) | AU2021308657A1 (https=) |
| CA (1) | CA3174068A1 (https=) |
| WO (1) | WO2022016043A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3033368A1 (en) * | 2016-08-12 | 2018-02-15 | University Of Massachusetts | Conjugated oligonucleotides |
| JP7627042B2 (ja) | 2018-08-23 | 2025-02-05 | ユニバーシティー オブ マサチューセッツ | Ｏ－メチルリッチ完全安定化オリゴヌクレオチド |
| US12365894B2 (en) | 2019-09-16 | 2025-07-22 | University Of Massachusetts | Branched lipid conjugates of siRNA for specific tissue delivery |
| WO2021242883A1 (en) | 2020-05-26 | 2021-12-02 | University Of Massachusetts | Synthetic oligonucleotides having regions of block and cluster modifications |
| US12366070B2 (en) | 2021-04-23 | 2025-07-22 | Stephen Cochran | Cover for circular-profile downspouts having protection from animal/insect intrusion and damage/debris accumulation |
| IL317825A (en) | 2022-07-25 | 2025-02-01 | Amgen Inc | RNA interference constructs and methods for inhibiting fam13a expression |
| US20260049309A1 (en) * | 2022-08-15 | 2026-02-19 | Novo Nordisk A/S | Regulation of activity of rnai molecules |
| WO2024069235A2 (en) | 2022-09-30 | 2024-04-04 | Sixfold Bioscience Ltd. | Compositions containing oligonucleotides with theranostic applications |
| WO2025217569A1 (en) * | 2024-04-11 | 2025-10-16 | University Of Massachusetts | Conjugated chemically-modified dsrna during ex vivo perfusion of organs |
| WO2025259747A2 (en) * | 2024-06-12 | 2025-12-18 | Alnylam Pharmaceuticals, Inc. | Dystrophy myotonic protein kinase (dmpk) irna compositions and methods of use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9745574B2 (en) * | 2009-02-04 | 2017-08-29 | Rxi Pharmaceuticals Corporation | RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality |
| CA3033368A1 (en) * | 2016-08-12 | 2018-02-15 | University Of Massachusetts | Conjugated oligonucleotides |
| EP3517610A4 (en) * | 2016-09-23 | 2020-05-27 | National University Corporation Tokyo Medical and Dental University | THROUGH HETERODUPLEX NUCLEIC ACID THROUGH BLOOD BRAIN CABINET |
| WO2019217459A1 (en) * | 2018-05-07 | 2019-11-14 | Alnylam Pharmaceuticals, Inc. | Extrahepatic delivery |
| JP2023550485A (ja) * | 2020-11-23 | 2023-12-01 | ユニバーシティー オブ マサチューセッツ | Ｄｇａｔ２調節のためのオリゴヌクレオチド |
-
2021
- 2021-07-16 CN CN202180061336.7A patent/CN116600817A/zh active Pending
- 2021-07-16 EP EP21843183.1A patent/EP4181932A4/en active Pending
- 2021-07-16 AU AU2021308657A patent/AU2021308657A1/en active Pending
- 2021-07-16 JP JP2023502828A patent/JP2023534951A/ja active Pending
- 2021-07-16 US US17/377,632 patent/US20220042015A1/en active Pending
- 2021-07-16 CA CA3174068A patent/CA3174068A1/en active Pending
- 2021-07-16 WO PCT/US2021/041946 patent/WO2022016043A1/en not_active Ceased